Markets:

Overview

News

Currencies

International

Treasuries

Jasper Therapeutics, Inc. - Class A Common Stock (NQ:JSPR)

0.4850 +0.0320 (+7.06%)

Streaming Delayed Price Updated: 10:25 AM EDT, Jun 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jasper Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

September 21, 2025

From The Schall Law Firm

Via Business Wire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR

September 21, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

September 20, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 18, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

September 18, 2025

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

Jasper Reports Wider Loss in Fiscal Q2 ↗

August 13, 2025

Via The Motley Fool

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

August 13, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

August 09, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

August 05, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

August 01, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

July 28, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

July 23, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

July 18, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

July 14, 2025

From Pomerantz LLP

Via GlobeNewswire

JSPR Investors Have Opportunity to Join Jasper Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

July 11, 2025

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

July 10, 2025

From Pomerantz LLP

Via GlobeNewswire

Jasper Therapeutics Gets Hit With Downgrades Over Faulty Batch Of Skin Allergy Drug; Retail Sees ‘Overreaction’ ↗

July 08, 2025

The company flagged that 10 of 13 patients in two dosing cohorts received a compromised batch of briquilimab, leading to muted results.

Via Stocktwits

Top stock movements in today's session. ↗

July 07, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem ↗

July 07, 2025

Jasper shares drop after updated BEACON study shows strong results but faces disruption from compromised drug product lot and halted pipeline programs.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 07, 2025

Via Benzinga

Dow Dips 1%; Mustang Bio Shares Spike Higher ↗

July 07, 2025

Via Benzinga

Topics Stocks

Here are the top movers in Monday's session. ↗

July 07, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

July 07, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS ↗

July 07, 2025

Via Benzinga

What's going on in today's pre-market session ↗

July 07, 2025

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 07, 2025

Via Benzinga

Russell 2000 Index Forecast As The Crash Continues: Buy The Dip? ↗

April 22, 2025

The Russell 2000 Index has plunged and formed a death cross this year as American stocks sink amid rising worries about Donald Trump’s policies.

Via Talk Markets

Topics Government Stocks / Equities

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 08, 2025

Via Benzinga

Crude Oil Down 1%; US Weekly Jobless Claims Decline ↗

January 08, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.